Sidley represented Amag Pharmaceuticals, Inc. (NASDAQ: AMAG) in the successful amicable resolution of the client’s proxy contest with Caligan Partners.
Sidley’s team was led by partners and co-chairs of Sidley’s shareholder activism practice Kai Haakon E. Liekefett and Derek Zaba, and includes associates Jessica Wood, Kathy Wang, Riley Kelleher and Anna Razzaio. Partner Alex J. Kaplan provided litigation advice, and partner John Kelsh advised on executive compensation matters.
This website uses cookies. Analytical cookies help us improve our website by providing insight on how visitors interact with our site, and necessary cookies which the website needs to function properly.
Necessary Cookies
The website cannot function properly without these necessary cookies, and they can only be disabled by changing your browser preferences. To learn more about these cookies, how we use them on our website, and how to revise your cookie settings, please view our cookie policy.
You have successfully set your edition to United States. Would you like to make this selection your default edition?
*Selecting a default edition will set a cookie.
This website uses cookies. Analytical cookies help us improve our website by providing insight on how visitors interact with our site, and necessary cookies which the website needs to function properly.
Necessary Cookies
The website cannot function properly without these necessary cookies, and they can only be disabled by changing your browser preferences. To learn more about these cookies, how we use them on our website, and how to revise your cookie settings, please view our cookie policy.